S.Korean drugmakers fall after cancer-causing chemicals found in diabetes products
** South Korea's Ministry of Food and Drug Safety suspends https://bit.ly/2X3v6vr
sales and production of 31 of metformin diabetes drugs, in
which it finds cancer-causing chemicals
** Shares of South Korea's Jin Yang Pharmaceutical
007370.KQ dive 11%; peers Yuhan Corp 000100.KS down 2.1% and
JW Pharmaceutical Corp 001060.KS down 3.9%
** The benchmark KOSPI market .KS11 was up 0.4%
Recent news on JW Pharmaceutical
See all newsBrief: Jw Pharmaceutical Q3 Operating Profit 32.6 Billion Won, Up 24% From Year Earlier
Brief: Jw Pharmaceutical Q2 Operating Profit 25.4 Billion Won, Up 103.3% From Year Earlier
Brief: Jw Pharmaceutical Q1 Operating Profit 22.6 Billion Won, Down 15.4% From Year Earlier
Brief: Jw Pharmaceutical To Acquire 5 Billion Won Worth Of Own Shares
Brief: Jw Pharmaceutical To Acquire 5 Billion Won Worth Of Own Shares